The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

Arbidol (ARB) is a synthetic antiviral originally developed to combat influenza viruses. ARB is currently used clinically in several countries but not in North America. We have previously shown that ARB inhibits in vitro hepatitis C virus (HCV) by blocking HCV entry and replication. In this report,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Virol
Auteurs principaux: Pécheur, Eve-Isabelle, Borisevich, Viktoriya, Halfmann, Peter, Morrey, John D., Smee, Donald F., Prichard, Mark, Mire, Chad E., Kawaoka, Yoshihiro, Geisbert, Thomas W., Polyak, Stephen J.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2016
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4810626/
https://ncbi.nlm.nih.gov/pubmed/26739045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02077-15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires